Editas Medicine stock hits 52-week low at $2.7 amid market challenges By Investing.com
Editas Medicine , Inc. (NASDAQ: NASDAQ:) stock has tumbled to a 52-week low, reaching a price level of just $2.7....
Read moreDetailsLatest Post
Instruments of Jeff Beck, one of rock’s greatest guitarists, up for auction
Musicians, collectors and fans have a chance to own a guitar god’s tools of the trade – instruments owned by...
Read moreDetailsMore Than 1,700 Fossil Fuel Lobbyists at UN Climate Negotiations
At least 1,773 fossil fuel lobbyists are attending the U.N. climate negotiations now underway in Baku, Azerbaijan, according to a...
Read moreDetails
Scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness
T cells are removed from the patient's body, engineered to fight disease, then infused back into the patient's bloodstream. At...
Read moreDetails
November 15, 2024 – 1400 UTC
November 15, 2024 - 1400 UTC Source link
Read moreDetails